John G Ph D Baust Net Worth

The estimated Net Worth of John G Ph D Baust is at least $83.5 Million dollars as of 14 April 2006. John Baust owns over 1,942,000 units of Biolife Solutions Inc stock worth over $83,499,792 and over the last 21 years John sold BLFS stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

John Baust BLFS stock SEC Form 4 insiders trading

John has made over 1 trades of the Biolife Solutions Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently John exercised 1,942,000 units of BLFS stock worth $77,680 on 14 April 2006.

The largest trade John's ever made was exercising 1,942,000 units of Biolife Solutions Inc stock on 14 April 2006 worth over $77,680. On average, John trades about 647,333 units every 0 days since 2004. As of 14 April 2006 John still owns at least 3,600,681 units of Biolife Solutions Inc stock.

You can see the complete history of John Baust stock trades at the bottom of the page.

What's John Baust's mailing address?

John's mailing address filed with the SEC is C/O BIOLIFE SOLUTIONS, INC., SCIENCE 3 SUITE 144 SUNY PARK, BINGHAMTON, NY, 13902.

Insiders trading at Biolife Solutions Inc

Over the last 21 years, insiders at Biolife Solutions Inc have traded over $156,215,880 worth of Biolife Solutions Inc stock and bought 12,236,637 units worth $91,960,074 . The most active insiders traders include Partners Master Fund, L.P.C..., Thomas Girschweiler, and Walter Villiger. On average, Biolife Solutions Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,018,157. The most recent stock trade was executed by Sarah Aebersold on 1 July 2024, trading 3,000 units of BLFS stock currently worth $63,090.

What does Biolife Solutions Inc do?

bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.

Complete history of John Baust stock trades at Biolife Solutions Inc

Biolife Solutions Inc executives and stock owners

Biolife Solutions Inc executives and other stock owners filed with the SEC include:

• Michael Rice,
  President, Chief Executive Officer, Director
• Aby Mathew,
  Executive Vice President and Chief Scientific Officer
• Roderick de Greef,
  Chief Financial Officer, Chief Operating Officer, Secretary, IR Contact Officer
• Michael P. Rice,
  Chairman & CEO
• Dr. Aby J. Mathew,
  Chairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer
• Roderick de Greef,
  Pres & COO
• Karen Foster,
  Chief Quality Officer
• Troy Wichterman,
  Chief Financial Officer
• Todd Berard,
  Chief Marketing Officer
• Raymond Cohen,
  Independent Chairman of the Board
• Joseph Schick,
  Independent Director
• Andrew Hinson,
  Independent Director
• Thomas Girschweiler,
  Director
• Karen Foster,
  Chief Quality Officer
• Marcus Schulz,
  Vice President, Global Sales
• Todd Berard,
  Chief Marketing Officer
• Marcus Schulz,
  Chief Revenue Officer
• Sarah Aebersold J.D.,
  VP of Global HR
• Frederick Stewart,
  Director
• Thomas Girschweiler,
  Director
• Joe Annicchiarico,
  Chief Operating Officer
• Daphne Taylor,
  Chief Financial Officer
• Matt Snyder,
  Vice President
• Walterwavi Holding Ag Villiger,
  
• Partners Master Fund, L.P.C...,
  
• Geraint Phillips,
  SVP, Global Operations
• Timothy L. Moore,
  Director
• Amy Du Ross,
  Director
• Rachel Ellingson,
  Director
• Walter Villiger,
  10% owner
• John G Ph D Baust,
  Director
• Howard S Breslow,
  Director
• Alan F Rich,
  Vice President
• Buskirk Robert Van,
  Director
• James Mathers,
  Chief Revenue Officer
• Dusty Tenney,
  COO and President
• Joydeep Goswami,
  Director
• Troy Wichterman,
  Chief Financial Officer
• Sarah Aebersold,
  Chief Human Resources Officer
• Garrie Richardson,
  Chief Revenue Officer